Contract facts
UnrestrictedNo full NAICS 621511 intel page yet. Browse NAICS intelligence
Molecular Thyroid Testing First Year Funding RMR VA is a federal Unrestricted award for Network Contract Office 19 (36C259) held by Cytopath Biopsy Lab Inc. Estimated value $230K ($230K obligated). Current period of performance ends Sep 24, 2027. Last award drew 3 bidders. Place of performance: RYE BROOK NY.
Molecular thyroid testing first year funding rmr va
Recompete timing
PublicCurrent PoP ends Sep 24, 2027 (342 days remaining). Agencies typically plan 12–18 months ahead — at 11.2 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C25926N0501? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordCytopath Biopsy Lab Inc — $5.9M obligated across 72 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25926N0501?
36C25926N0501 (Molecular thyroid testing first year funding) is a Network Contract Office 19 (36C259) award with a potential value of $230K, currently held by Cytopath Biopsy Lab Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C259-26-N-0501?
36C259-26-N-0501 is the dashed form of PIID 36C25926N0501 (Molecular thyroid testing first year funding), held by Cytopath Biopsy Lab Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25926N0501?
Network Contract Office 19 (36C259) awarded 36C25926N0501 to Cytopath Biopsy Lab Inc (potential $230K).
Who is the incumbent on 36C25926N0501?
Cytopath Biopsy Lab Inc is the incumbent with $5.9M across 72 related awards in SCOUT’s public footprint. The current period of performance ends Sep 24, 2027.
When does Cytopath Biopsy Lab Inc’s 36C25926N0501 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 24, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C25926N0501? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.